Zenith Energy Rated “B+” with Stable Outlook

Zenith Energy Ltd., (LON: ZEN; TSX.V: ZEE; OSE: ZENA-ME), the international oil & gas production company, has today announced that Rating-Agentur Expert RA has assigned Zenith a “B+” with Stable Outlook debt issuer credit rating.

RAEX is an independent European Credit Rating Agency with more than 20 years of experience in the rating and analytical industry. It is registered with the European Securities and Markets Authority (“ESMA”) and received ECAI status (External Credit Assessment Institution) in 2015.

The RAEX report can be viewed here: https://raexpert.eu/reports/Press_release_Zenith_Energy_Ltd.18.11.2019.pdf

Andrea Cattaneo, Chief Executive Officer of Zenith Energy, commented:
“The Board is pleased to have received an additional credit rating from an established European credit rating agency.
This rating is expected to help the Company successfully distribute its debt instruments, especially following the recent approval of Zenith’s Prospectus document for the issuance of up to EUR 25 million EMTNs.”

Share on:

Written by: Giles Arbor

Find more news, interviews, share price & company profile here for:

Latest Company News

JPMorgan European Discovery Trust reports strong performance uplift in latest factsheet

JPMorgan European Discovery Trust reported a 5.37% share price rise in July 2025, outpacing NAV and its benchmark. Year-to-date, the share price is up 34.17%, supported by strong small-cap performance and effective stock selection.

Golden Matrix reports record August revenue of $17.8m, up 18% year-on-year

Golden Matrix posted record August revenues of $17.8m, up 18% from last year, with July revenues also rising 24% to $15.7m. Strong performance came from Meridianbet’s sports betting and RKings’ tournaments, positioning the group for record Q3 results.

HUTCHMED to present new lung cancer and oncology data at WCLC and CSCO 2025

HUTCHMED announced that updated data on savolitinib in NSCLC and other pipeline compounds will be presented at the World Conference on Lung Cancer in Barcelona and the CSCO Annual Meeting in China this September. Presentations include studies on savolitinib, surufatinib, fruquintinib and first-in-human results for HMPL-653.

Surface Transforms appoints Paul Marr as Non-Executive Director

Surface Transforms has appointed Paul Marr to its Board as Non-Executive Director. Marr brings over 40 years of global automotive manufacturing and operational leadership experience, including senior roles at General Motors and other international groups.

Avation signs 12-year lease for ATR 72-600 with Cambodian airline

Avation has agreed a twelve-year lease with a Cambodian carrier for a new ATR 72-600, the second of ten aircraft ordered in 2024. Delivery is scheduled for February 2026.

Tern Plc delivers stronger interim results with reduced loss and portfolio growth

Tern Plc reported improved interim results for the six months to 30 June 2025, with a 64% reduction in loss, disciplined cost control, and a new strategic investment in Sure Ventures plc. The company also strengthened portfolio support through successful fundraises.